Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530957 | SCV000637315 | likely benign | Familial meningioma | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000561677 | SCV000675244 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001093344 | SCV001250276 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SMARCE1: BP4, BP7 |
Gene |
RCV001093344 | SCV003853049 | likely benign | not provided | 2019-03-13 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
KCCC/NGS Laboratory, |
RCV003316703 | SCV004015529 | likely benign | Rhabdoid tumor predisposition syndrome 1 | 2023-07-07 | criteria provided, single submitter | clinical testing |